Trypsin-mediated
trypsinogen activation (autoactivation) facilitates digestive
zymogen activation in the duodenum but may precipitate
pancreatitis if it occurs prematurely in the pancreas. Autoactivation of human cationic
trypsinogen is inhibited by a repulsive electrostatic interaction between the unique Asp218 on the surface of cationic
trypsin and the conserved tetra-
aspartate (Asp19-22) motif in the
trypsinogen activation peptide (Nemoda, Z., and Sahin-Tóth, M. (2005) J. Biol. Chem. 280, 29645-29652). Here we describe that this interaction is regulated by
chymotrypsin C (
caldecrin), which can specifically cleave the Phe18-Asp19
peptide bond in the
trypsinogen activation peptide and remove the N-terminal tripeptide. In contrast,
chymotrypsin B,
elastase 2A, or
elastase 3A (
proteinase E) are ineffective. Autoactivation of N-terminally truncated cationic
trypsinogen is stimulated approximately 3-fold, and this effect is dependent on the presence of Asp218. Because
chymotrypsinogen C is activated by
trypsin, and
chymotrypsin C stimulates
trypsinogen activation, these reactions establish a positive feedback mechanism in the digestive
enzyme cascade of humans. Furthermore, inappropriate activation of
chymotrypsinogen C in the pancreas may contribute to the development of
pancreatitis. Consistent with this notion, the
pancreatitis-associated mutation A16V in cationic
trypsinogen increases the rate of
chymotrypsin C-mediated processing of the activation
peptide 4-fold and causes accelerated
trypsinogen activation in vitro.